Global X S&P Biotech ETF
CURE
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,125.20 | 111.50 | 1.39% |
| CAC 40 | 7,482.36 | 155.89 | 2.13% |
| DAX 40 | 21,961.97 | 668.44 | 3.14% |
| Dow JONES (US) | 39,606.57 | 419.59 | 1.07% |
| FTSE 100 | 8,403.18 | 74.58 | 0.90% |
| HKSE | 22,072.62 | 510.30 | 2.37% |
| NASDAQ | 16,708.05 | 407.63 | 2.50% |
| Nikkei 225 | 34,868.63 | 648.03 | 1.89% |
| NZX 50 Index | 12,002.58 | 46.11 | 0.39% |
| S&P 500 | 5,375.86 | 88.10 | 1.67% |
| S&P/ASX 200 | 7,920.50 | 103.80 | 1.33% |
| SSE Composite Index | 3,296.36 | 3.40 | -0.10% |